PURPOSE: A case report of a 40-year-old patient with tuberculosis treated with ethambutol is described. Within six months of starting treatment, there was a painless sudden decline in visual function. Despite the known complications of ethambutol treatment, it was discontinued after another three months. METHODS: In the case report, we highlight the damage to the dominantly peripheral visual pathways. Using electrophysiological examinations, we showed a significant alteration in the optic nerves. Optical Coherence Tomography (OCT) showed progressive loss of vessel density and nerve fibre layer of retinal ganglion cells. Perimetric examination showed both a central decrease in sensitivity and mainly scotomas in the temporal parts of the visual fields. Although there was improvement in visual fields over time, OCT findings indicated progression of ethambutol-induced optic neuropathy (EON). Magnetic Resonance Imaging confirmed the alteration in the peripheral part of the visual pathway (intraorbital, intracranial parts of optic nerves, chiasma, and optic tracts). CONCLUSION: Even though EON is not an unknown complication, new cases still occur and, unfortunately, with an irreversible course. Therefore, it is important to draw attention constantly to this complication and to consider it not only in ophthalmologists' surgeries.

Faculty of Biomedical Engineering Czech Technical University Prague 272 01 Kladno

Zobrazit více v PubMed

Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J 2006;12:56-60. PubMed

Carr RE, Henkind P. Ocular manifestations of ethambutol, toxic amblyopia after administration of an experimental antituberculous drug. Arch Ophthalmol 1962;67:566-71. PubMed DOI

Woung LC, Jou JR, Liaw SL. Visual function in recovered ethambutol optic neuropathy. J Ocul Pharmacol Ther 1995;11:411-19. PubMed DOI

Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther 1997;13:473-77. PubMed DOI

Barron GJ, Tepper L, Iovine G. Ocular toxicity from ethambutol. Am J Ophthalmol 1974;77:256-60. PubMed DOI

Holcová B, Száhalová D. Ocular complications in ethambutol treatment. Čs Oftal 1975;31:256-59. (In Czech)

Krchnavá B, Slámová J. The toxicak effect of ethambutol on tbc visual organ. Čs Oftal 1976;32:39-44. (In Czech)

Stibor V, Lachmanová J, Tomášek R. Ocular complications of antituberculoties in patients with regular dialysis. Čs Oftal 1989;45:62-64. (In Czech)

Liška V, Vitvarová J. Toxic damage of optic nerve during ethambutol treatment in a chronically dialyzed patient. Čs Oftal 1991;47:133-37. (In Czech)

Základní přehled epidemiologické situace ve výskytu tuberkulózy v České republice v roce 2019. ÚZIS ČR. [cited 2021 Dec 20] Available from: https://www.uzis.cz/res/f/008314/tbc2019-cz.pdf (In Czech)

Leibold JE. The ocular toxicity of ethambutol and its relation to dose. Ann N Y Acad Sci 1966;135:904-09. PubMed DOI

Kahana L M. Toxic ocular effects of ethambutol. CMAJ. 1987;137:213-16. PubMed

Russo P A, Chaglasian M A. Toxic optic neuropathy associated with ethambutol: implications for current therapy. J Am Optom Assoc 1994;65:332-38. PubMed

Chamberlain PD, Sadaka A, Berry S, Lee AG. Ethambutol optic neuropathy. Curr Opin Ophthalmol 2017;28:545-51. PubMed DOI

Koul PA. Ocular toxicity with ethambutol therapy: Timely recaution. Lung India 2015;32:1-3. PubMed DOI

Schmidt IG, Schmidt LH. Studies of neurotoxocity of ethambutol and its racemate for the rhesus monkey. J Neuropath Exp Neurol 1966;25:40-67. DOI

Schmidt IG. Central nervous system effects of ethambutol in monkeys. Ann NY Acad Sci 1966;135:759-74. PubMed DOI

Lessell S. Histopathology of experimental ethambutol intoxication. Invest Ophthalmol Vis Sci 1976;15:765-69. PubMed

Karnik AM, Al-Shamali MA, Fenech FF. A case of ocular toxicity to ethambutol-an idiosyncratic reaction? Postgrad Med J 1985;61:811-13. PubMed DOI

Chawla JPS, Crisan E, Jay WM. Ethambutol chiasmal toxicity with bitemporal hemianopia. Semin Ophthalmol 2009;24:221-24. DOI

Kho RC, Al-Obailan M, Arnold AC. Bitemporal visual field defects in ethambutol-induced optic neuropathy. J Neuroophthalmol 2011;31:121-26. PubMed DOI

Scemama EB, Touitou V, Le Hoang P. Bitemporal hemianopia as presenting sign of severe ethambutol toxicity. J Fr Ophtalmol 2013;36:163-67. PubMed DOI

Osaguona VB, Sharpe JA, Awaji SA, Farb RI, Sundaram AN. Optic chiasm involvement on MRI with ethambutol-inducted bitemporal hemianopia. J Neuroopthalmol 2014;34:155-58. PubMed DOI

Heng JE, Vorwerk CK, Lessell E, Zurakowski D, Levin LA, Dreyer EB. Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway. Invest Ophthalmol Vis Sci 1999;40:190-96. PubMed

Kim KL, Park S P. Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level. Cutan Ocul Toxicol 2016;35:228-32. PubMed DOI

Lee EJ, Kim SJ, Choung HK, Kim JH, Yu YS. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. J Neuroophthalmol 2008;28:269-77. DOI

Ezer N, Benedetti A, Darvish-Zargar M, Menzies D. Incidence of ethambutol- related visual impairment during treatment of active tuberculosis. Int J Tuberc Lung Dis 2013;17:447-55. PubMed DOI

Kuma A, Sandramouli,S, Verma L, Tewari HK, Khosla PK. Ocular ethambutol toxicity: is it reversible? J Clin Neuroophthalmol 1993;13:15-17. PubMed

Tsai RK, Lee YH. Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther 1997;13:473-77. PubMed DOI

Kumar A, Dada T. Visual evoked response (VER) in ocular ethambutol toxicity. Natl Med J India1999;12:193-94.